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EDITORIAL
Antipyretic use in children: more than just temperature☆,☆☆
Uso de antipiréticos em crianças: mais do que apenas temperatura
Edward Purssell
BSc, MSc, PhD, RGN, RSCN, FHEA. Senior Lecturer, Florence Nightingale School of Nursing and Midwifery, London, 
England, UK
One of the most remarkable facts about the treatment of 
febrile illness in children is that, despite its ubiquity and 
the plethora of guidelines, recommendations, and other 
publications, the exaggerated fear of fever (sometimes 
referred to as “fever phobia”) remains common around 
the world, and has remained so for many years.1 The 
result of this fear is that parents and professionals worry 
unduly about fever, and many over-treat febrile children. 
Some of these interventions at least reduce fever, such as 
antipyretic drugs; others don’t even achieve this, such as 
physical cooling. Another manifestation of this fear is the 
over-use or combination of antipyretic drugs, which is the 
focus of the study by Pereira et al.2
From a historical context, the fear of fever makes sense, 
as in the past, and even today in many parts of the world, 
infectious diseases are a cause not just of morbidity, but 
also of significant mortality, and even in countries with 
highly developed health systems children continue to die 
from undiagnosed serious infections. The important issue 
for caregivers and professionals alike is to separate the 
symptom of fever, which is a normal physiological response 
that poses no danger, from the underlying condition, which 
in a relatively small number of cases may be a serious 
illness.
The question of what role fever plays in the recovery 
from illness is complex. Fever results from the release 
and conversion of arachadonic acid from cellular lipid 
membranes into prostaglandin E2, through the action of 
the cyclooxygenase enzymes COX-1 and COX-2. The former, 
which is constitutively expressed, is thought to be primarily 
responsible for maintaining homeostasis. The latter, which is 
induced by a range of cytokines including IL-1 and TNF-a,3 is 
mainly responsible for fever and inflammation, a syndrome 
sometimes referred to as “acute phase response”. It is 
possible to construct both evolutionary and immunological 
arguments for the benefit of fever, based on its ubiquity 
throughout the animal kingdom and the important role 
of cytokines in the immune response. However, clinical 
studies have proved to be more difficult to conduct; even 
when performed, the results were not conclusive, and it 
is impossible to separate the possible beneficial effect of 
fever from the other parts of the acute phase response.4,5 
One study that demonstrated a reduced antibody response 
to some vaccine antigens in children given prophylactic 
paracetamol has led many countries to advise against the 
routine prophylactic use of antipyretics, but such evidence 
is rare.6
Although the benefits of fever are hard to define, what 
is known is that the symptom and the underlying illness are 
separate issues, and their clear separation may make the 
fear of fever itself easier to manage. We can be unequivocal: 
fever will not harm an otherwise well child, and the highly 
exaggerated concerns regarding brain damage and death as 
a result of fever are not warranted. However, as this and 
other studies show, we are some length from achieving this. 
One manifestation of this phobia is the co-administration or 
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alternation of antipyretic medicines such as paracetamol/
acetaminophen and NSAIDs such as ibuprofen/dipyrone, a 
practice that this study found to be common in Southern 
Brazil.2 As with fever phobia,this practice appears to be 
widespread throughout the world: a study in the United 
States showed that 67% of parents reported that they 
alternated antipyretics, and of these 81% reported being 
advised to do this by a healthcare professional,7 despite 
the American Academy of Pediatrics stating that there is 
insufficient evidence to support or refute this practice. 
The objections to this practice revolve around its unknown 
safety; a lack of evidence that it improves comfort, which is 
the primary goal of treatment; the possibility of confusion 
and consequent inaccurate or overdosing by parents; and 
the reinforcement of fever phobia.8
Although the primary objection may be one of safety, 
the reality is that despite this being a common practice, 
there has not been large numbers of reports of side-
effects or toxicities resulting from it. While there have 
been cases reported in the literature of toxicity associated 
with the combined use of these drugs,9 these remain rare. 
Furthermore, there are also case reports and case-studies 
of toxicities associated with each drug individually.10,11 
Meta-analyses and narrative reviews have failed to 
demonstrate any difference in safety between ibuprofen 
and paracetamol,12,13 or between either drug and combined 
or alternating treatments,14 although the studies reviewed 
were probably underpowered to identify such rare events, 
and lacked sensitivity due to short follow-up and passive 
reporting of side-effects.
Overdosing is a possible problem, and one that increases 
with the more drugs that caregivers provide. Interestingly, 
in this study, most doses that were given were below the 
recommended level, which may be one explanation as 
to why so many parents felt the need to give alternative 
drugs. Another clue as to the reason for alternating drugs 
may be the temperature at which caregivers defined fever. 
The mean temperature considered to be fever by caregivers 
in this study was only 37.4 ºC, which is actually within the 
normal range for most children,15 suggesting that at least 
some healthy children are treated for fever.2 As a treatment 
for fever, if required, there is some scientific rationale 
for combining these drugs, as they have different modes 
of action: ibuprofen is a non-selective cyclooxygenase 
inhibitor, and while the mode of action of paracetamol is 
not known with certainty, it is thought to act centrally, in 
a different manner than ibuprofen.16 However, guidelines 
emphasize the importance of not using these drugs with the 
sole aim of reducing temperature, but rather to use them 
to improve overall comfort.8 The problem with interpreting 
such recommendations is to know exactly what is meant 
by comfort, especially considering that fever is usually just 
one part of a complex acute phase response that includes 
immunological, physiological, and behavioral responses. 
Indeed, any apparent improvement from the treatment 
of fever with drugs that have a broad range of effects, 
including anti-inflammatory and analgesic actions, may 
be the result of these rather than, or in addition to, their 
effect on temperature.
However, use of antipyretics, either alone or in 
combination may have other benefits. Parents of sick 
children often feel that they have a responsibility to 
protect their children from being harmed by the illness, 
a need that has two aspects: the first is the threat posed 
by the illness; and the second is their sense of personal 
control in a situation where realistically they often have 
no control.17 By enabling parents to give medicines which 
they perceive as providing benefit, this might given 
them a sense of control, reducing their anxiety, and so 
perhaps also reducing anxiety in their children and their 
use of healthcare facilities.18 This may be linked to real 
improvements, but there may also be benefit in just 
administering something, whether this benefit is the result 
of a pharmacological effect caused by an active ingredient; 
some other property of the medicine, such as its taste; the 
psychological effect of doing something (the true placebo 
effect); or indeed just that it coincides with recovery.19
Although the focus of this study is the use of alternating 
antipyretics, there is another important detail that should 
be of concern, which is that 73% of respondents answered 
that their first action when their child had a temperature 
was to medicate them.2 Illness, with or without fever, does 
impose a metabolic burden on the child, and so maintaining 
fluid and nutrition is important. Even more important is 
ensuring that caregivers and non-pediatric specialists can 
differentiate between children at low, intermediate, and 
high risk of serious illness. While there is little evidence 
that the use of antipyretics either alone or in combination 
masks these signs and symptoms, the rush to use them 
as a first action might distract from their identification. 
It was for this reason that the United Kingdom National 
Institute for Health and Clinical Excellence (NICE) devised 
the “traffic light” system of signs and symptoms that are 
indicative of each category.20 This system, which is in the 
process of being updated in the light of new research, 
can be adapted for local use to encourage caregivers to 
concentrate on those most indicative of serious illness in 
each case.
Alongside the “traffic light” is the idea of safety net 
advice. Although not a new idea, the NICE guidelines 
included specific recommendations that the safety net 
should include one or more of the following: information 
on warning symptoms and how further healthcare can be 
accessed; further follow-up at a specific time and place; 
and liaison with other healthcare providers to ensure direct 
access if necessary. The way in which this is provided will 
differ from place to place, but in many circumstances it 
would include verbal and written information. The “traffic 
light” alongside with the safety net advice can be used to 
encourage caregivers to concentrate upon the important 
part of febrile illness, which is not the fever itself but 
what the fever is indicating, and providing appropriate 
supportive care.
Despite being one of the most common symptoms 
of illness in childhood, resulting in many consultations 
with healthcare providers, fever remains surprisingly 
misunderstood by professionals and caregivers alike. While 
there are some things about it that are known, there 
is much that is still to be understood. However, what 
can be stated quite clearly is that the most important 
action is the differentiation of those children with serious 
illness from those without. Following this should be 
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the issue of supportive care, ensuring that children are 
receiving sufficient fluids and calories, and that they are 
comfortable. If it is decided to give antipyretic medication, 
although not usually necessary, there are at least two safe 
and effective drugs available in most countries. Even in 
the absence of evidence of harm, it is never a good idea 
to encourage polypharmacy, which increases the risk of 
confusion, interactions with other drugs, and maintains the 
fear of fever itself.
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